1604610

Risedronate sodium

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): Risedronic acid monosodium salt hemi(pentahydrate)
• Empirical Formula (Hill Notation): C₇H₁₀NNaO₇P₂ · 2.5H₂O
• CAS Number: 329003-65-8
• Molecular Weight: 350.13
• MDL number: MFCD01706268
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: risedronate
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• InChI key: HYFDYHPNTXOPPO-UHFFFAOYSA-L

Description

General description

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

Application

Risedronate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Warning
• Hazard Statements: H302,H319,H361,H371
• Precautionary Statements: P202 - P260 - P264 - P301 + P312 - P305 + P351 + P338 - P308 + P311
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable